These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20823674)

  • 21. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone.
    Patton AJ; Genever PG; Birch MA; Suva LJ; Skerry TM
    Bone; 1998 Jun; 22(6):645-9. PubMed ID: 9626403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cystine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells.
    Iemata M; Takarada T; Hinoi E; Taniura H; Yoneda Y
    J Cell Physiol; 2007 Dec; 213(3):721-9. PubMed ID: 17520696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New role of glutamate as an immunoregulator via glutamate receptors and transporters.
    Xue H; Field CJ
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1007-20. PubMed ID: 21622250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of evidence is not evidence of absence. Redundancy blocks determination of cause and effect.
    Chenu C; Itzstein C; Espinosa L
    J Bone Miner Res; 2001 Sep; 16(9):1728-9; author reply 1731-2. PubMed ID: 11547845
    [No Abstract]   [Full Text] [Related]  

  • 25. Negative regulation of osteoblastogenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit.
    Uno K; Takarada T; Takarada-Iemata M; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
    J Cell Physiol; 2011 Nov; 226(11):2953-64. PubMed ID: 21302293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homeostatic regulation of glutamate neurotransmission in primary neuronal cultures.
    Briz V; Suñol C
    Methods Mol Biol; 2011; 758():253-65. PubMed ID: 21815071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of glutamatergic signaling machineries in pathophysiology of rheumatoid arthritis.
    Hinoi E; Yoneda Y
    J Pharmacol Sci; 2011; 116(3):248-56. PubMed ID: 21666346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate is a determinant of cellular proliferation through modulation of nuclear factor E2 p45-related factor-2 expression in osteoblastic MC3T3-E1 cells.
    Uno K; Takarada T; Hinoi E; Yoneda Y
    J Cell Physiol; 2007 Oct; 213(1):105-14. PubMed ID: 17443688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
    Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
    J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.
    Peet NM; Grabowski PS; Laketic-Ljubojevic I; Skerry TM
    FASEB J; 1999 Dec; 13(15):2179-85. PubMed ID: 10593865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular glutamate alters mature osteoclast and osteoblast functions.
    Seidlitz EP; Sharma MK; Singh G
    Can J Physiol Pharmacol; 2010 Sep; 88(9):929-36. PubMed ID: 20921979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excitatory amino acid transporters expressed by synovial fibroblasts in rats with collagen-induced arthritis.
    Hinoi E; Ohashi R; Miyata S; Kato Y; Iemata M; Hojo H; Takarada T; Yoneda Y
    Biochem Pharmacol; 2005 Dec; 70(12):1744-55. PubMed ID: 16242118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate signalling and its potential application to tissue engineering of bone.
    Mason DJ
    Eur Cell Mater; 2004 Apr; 7():12-25; discussion 25-6. PubMed ID: 15073696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamate transporters as drug targets.
    Hinoi E; Takarada T; Tsuchihashi Y; Yoneda Y
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):211-20. PubMed ID: 15857305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supporting evidence for negative modulation by protons of an ion channel associated with the N-methyl-D-aspartate receptor complex in rat brain using ligand binding techniques.
    Yoneda Y; Enomoto R; Ogita K
    Brain Res; 1994 Feb; 636(2):298-307. PubMed ID: 7516810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine.
    Ito K; Abekawa T; Koyama T
    Psychopharmacology (Berl); 2006 Aug; 187(3):293-302. PubMed ID: 16850286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamatergic innervation in bone.
    Chenu C
    Microsc Res Tech; 2002 Jul; 58(2):70-6. PubMed ID: 12203705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Signaling factors in a variety of cells derived from mesenchymal stem cells].
    Takarada T
    Yakugaku Zasshi; 2012; 132(10):1145-9. PubMed ID: 23037699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ionotropic glutamate receptors in cerebral microvascular endothelium are functionally linked to heme oxygenase.
    Parfenova H; Fedinec A; Leffler CW
    J Cereb Blood Flow Metab; 2003 Feb; 23(2):190-7. PubMed ID: 12571450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current perspectives on NMDA-type glutamate signalling in bone.
    Spencer GJ; McGrath CJ; Genever PG
    Int J Biochem Cell Biol; 2007; 39(6):1089-104. PubMed ID: 17188550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.